Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine
February 07, 2022 07:00 ET
|
Theralase Technologies Inc.
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...